Insider Buying: Oxford Instruments plc (LON:OXIG) Insider Buys 8 Shares of Stock

Oxford Instruments plc (LON:OXIG) insider Richard Tyson purchased 8 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was bought at an average price of GBX 1,952 ($24.19) per share, with a total value of £156.16 ($193.51).

Oxford Instruments Price Performance

LON:OXIG traded up GBX 49.24 ($0.61) on Monday, hitting GBX 1,977.24 ($24.50). The company had a trading volume of 70,772 shares, compared to its average volume of 144,453. The firm has a 50 day moving average of GBX 2,081.15 and a two-hundred day moving average of GBX 2,138.82. The stock has a market capitalization of £1.15 billion, a price-to-earnings ratio of 2,299.12, a PEG ratio of -3.56 and a beta of 0.96. Oxford Instruments plc has a 52 week low of GBX 1,870 ($23.17) and a 52 week high of GBX 2,765 ($34.26). The company has a current ratio of 1.64, a quick ratio of 1.11 and a debt-to-equity ratio of 12.96.

Oxford Instruments (LON:OXIG) last issued its quarterly earnings results on Tuesday, November 12th. The company reported GBX 44.70 ($0.55) earnings per share (EPS) for the quarter. Oxford Instruments had a net margin of 10.78% and a return on equity of 14.29%. On average, research analysts anticipate that Oxford Instruments plc will post 117.7149452 earnings per share for the current year.

Oxford Instruments Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, January 10th. Investors of record on Thursday, November 28th were paid a dividend of GBX 5.10 ($0.06) per share. This represents a yield of 0.24%. The ex-dividend date of this dividend was Thursday, November 28th. Oxford Instruments’s dividend payout ratio is presently 2,441.86%.

Analysts Set New Price Targets

OXIG has been the topic of several research reports. Berenberg Bank decreased their price objective on shares of Oxford Instruments from GBX 2,925 ($36.25) to GBX 2,830 ($35.07) and set a “buy” rating on the stock in a report on Tuesday, November 12th. Shore Capital restated a “buy” rating on shares of Oxford Instruments in a research report on Wednesday, October 16th.

About Oxford Instruments

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.
Innovation is the driving force behind Oxford Instruments’ growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world.